Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity

被引:131
作者
Harris, JB
Khan, AI
LaRocque, RC
Dorer, DJ
Chowdhury, F
Faruque, ASG
Sack, DA
Ryan, ET
Qadri, F
Calderwood, SB
机构
[1] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA
[3] ICDDR, B, Ctr Hlth & Populat Res, Dhaka, Bangladesh
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[5] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
关键词
D O I
10.1128/IAI.73.11.7422-7427.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Individuals with blood group O are more susceptible than other individuals to severe cholera, although the mechanism underlying this association is unknown. To assess the respective roles of both intrinsic host factors and adaptive immune responses that might influence susceptibility to infection with Vibrio cholerae, we prospectively followed a cohort of household contacts of patients with cholera in Bangladesh. In this study, we made the novel observation that persons with blood group O were less likely than those with other blood groups to become infected with V. cholerae O1 (odds ratio [OR], 0.67; 95% confidence interval [CI], 0.53 to 0.85; P = 0.008). Consistent with prior studies, however, household contacts with blood group O were more likely to develop severe illness if infected with V. cholerae O1 (OR, 2.3; 95% CI, 0.98 to 5.59; P = 0.05). While blood group O protected significantly against infection with V. cholerae O1, there was no evidence of protection against V. cholerae O139. A multivariate analysis demonstrated that the association between blood group O and protection from infection with V. cholerae O1 was independent of age, gender, and baseline anti-cholera toxin and vibriocidal antibody titers. Based on this epidemiologic evidence, we propose a hypothesis for understanding the association between blood group O and the risk of infection with V. cholerae O1 and O139 as well as the risk of developing severe symptoms once infected.
引用
收藏
页码:7422 / 7427
页数:6
相关论文
共 29 条
[11]   CHOLERA [J].
KAPER, JB ;
MORRIS, JG ;
LEVINE, MM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (01) :48-86
[12]   ATTENUATED LIVE CHOLERA VACCINE STRAIN CVD-103-HGR ELICITS SIGNIFICANTLY HIGHER SERUM VIBRIOCIDAL ANTIBODY-TITERS IN PERSONS OF BLOOD-GROUP-O [J].
LAGOS, R ;
AVENDANO, A ;
PRADO, V ;
HORWITZ, I ;
WASSERMAN, S ;
LOSONSKY, G ;
CRYZ, S ;
KAPER, JB ;
LEVINE, MM .
INFECTION AND IMMUNITY, 1995, 63 (02) :707-709
[13]   GENETIC SUSCEPTIBILITY TO CHOLERA [J].
LEVINE, MM ;
NALIN, DR ;
RENNELS, MB ;
HORNICK, RB ;
SOTMAN, S ;
VANBLERK, G ;
HUGHES, TP ;
ODONNELL, S ;
BARUA, D .
ANNALS OF HUMAN BIOLOGY, 1979, 6 (04) :369-374
[14]   Human susceptibility and resistance to Norwalk virus infection [J].
Lindesmith, L ;
Moe, C ;
Marionneau, S ;
Ruvoen, N ;
Jiang, X ;
Lindbland, L ;
Stewart, P ;
LePendu, J ;
Baric, R .
NATURE MEDICINE, 2003, 9 (05) :548-553
[15]   INHIBITION OF CHOLERA-TOXIN BINDING TO MEMBRANE-RECEPTORS BY PIG GASTRIC MUCIN-DERIVED GLYCOPEPTIDES - DIFFERENTIAL EFFECT DEPENDING ON THE ABO BLOOD-GROUP ANTIGENIC DETERMINANTS [J].
MONFERRAN, CG ;
ROTH, GA ;
CUMAR, FA .
INFECTION AND IMMUNITY, 1990, 58 (12) :3966-3972
[16]  
MOSLEY WH, 1968, B WORLD HEALTH ORGAN, V38, P777
[17]  
MOSLEY WH, 1968, B WORLD HEALTH ORGAN, V38, P335
[18]   PRODUCTION, CHARACTERIZATION, AND APPLICATION OF MONOCLONAL-ANTIBODIES TO VIBRIO-CHOLERAE O139 SYNONYM BENGAL [J].
QADRI, F ;
AZIM, T ;
CHOWDHURY, A ;
HOSSAIN, J ;
SACK, RB ;
ALBERT, MJ .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (01) :51-54
[19]   Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh [J].
Qadri, F ;
Chowdhury, MI ;
Faruque, SM ;
Salam, MA ;
Ahmed, T ;
Begum, YA ;
Saha, A ;
Alam, MS ;
Zaman, K ;
Seidlein, LV ;
Park, E ;
Killeen, KP ;
Mekalanos, JJ ;
Clemens, JD ;
Sack, DA .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (04) :573-579
[20]   COMPARISON OF THE VIBRIOCIDAL ANTIBODY-RESPONSE IN CHOLERA DUE TO VIBRIO-CHOLERAE-O139 BENGAL WITH THE RESPONSE IN CHOLERA DUE TO VIBRIO-CHOLERAE-O1 [J].
QADRI, F ;
MOHI, G ;
HOSSAIN, J ;
AZIM, T ;
KHAN, AM ;
SALAM, MA ;
SACK, RB ;
ALBERT, MJ ;
SVENNERHOLM, AM .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (06) :685-688